Jane Street Group, LLC Pmv Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 49,870 shares of PMVP stock, worth $70,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,870
Previous 74,089
32.69%
Holding current value
$70,316
Previous $110,000
31.82%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding PMVP
# of Institutions
78Shares Held
41.8MCall Options Held
500Put Options Held
500-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.13 Million0.26% of portfolio
-
Sio Capital Management, LLC New York, NY3.57MShares$5.04 Million2.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.51MShares$4.95 Million0.08% of portfolio
-
Bml Capital Management, LLC Zionsville, IN3.47MShares$4.89 Million3.25% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.7 Million0.54% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $64.3M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...